RE:The $1.50 PPpointer wrote: Lets see if KNR can deliver more than one-half of one percent of their much touted 20,000 number. That doesn't seem like too much to ask, does it?
To me it seems quite a lot to ask considering that in the first three months they sold 10 units instead of 60,000. One-half of one percent would have been 300, but they managed only one-thirtieth of that. That indescribably pathetic. Meanwhile, by their own admission they built "hundreds" of units, so it wasn't a chip shortage that held them to 10. It was their conceit and ineptitude. I haven't seen signs that that has changed much, if at all. In fact the PP indicates it's just getting worse. Ghezzi tweeted that the company was undervalued at $3-plus share price. He then proceeded to massively devalue the company, first with the pathetic guidance number, which immediately slashed a third off the share price, then by selling the PP at $1.50 per share (not even accounting for the warrants and the dilution) to feed his vanity fantasy project of getting a NASDAQ listing. Sorry, but based on everything he's done since Biocloud was first invented, Ghezzi is as likely to deliver improvement as he is to deliver a baby.